A. Lipton

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

Mark D. Pegram, A. Lipton, Daniel F. Hayes et al. · Journal of Clinical Oncology · 1998 · 1.1K citations

Medicine, Oncology, Pharmacology +17

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

G. N. Hortobagyi, Richard L. Theriault, A. Lipton et al. · Journal of Clinical Oncology · 1998 · 632 citations

Medicine, Oncology, Pharmacology +17

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

Kim Leitzel, Y A Teramoto, Kerstin Konrad et al. · Journal of Clinical Oncology · 1995 · 300 citations

Medicine, Endocrinology, Oncology +16

The Physical and Biological Characterization of a Frail Mouse Model

Jeremy Walston, Neal S. Fedarko, Huan Yang et al. · The Journals of Gerontology Series A · 2008 · 188 citations · Full text

Medicine, Geriatric Medicine, Immunology +16

Serum <i>HER-2/neu</i> and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen

A. Lipton, Suhail M. Ali, Kim Leitzel et al. · Journal of Clinical Oncology · 2003 · 125 citations

Medicine, Oncology, Pharmacology +17